Whitehawk Therapeutics (WHWK) Amortizatization of Intangibles (2023 - 2026)
Whitehawk Therapeutics (WHWK) posted quarterly Amortizatization of Intangibles of $347000.0 for Q1 2026, up 1926.32% year-over-year from $17124.7 in Q1 2025, and down 58.24% quarter-over-quarter from $831000.0 in Q4 2025.
Powered by 
Analysis
Whitehawk Therapeutics (WHWK) Amortizatization of Intangibles (2023 - 2026) Analysis & Trends
Whitehawk Therapeutics (WHWK) has reported Amortizatization of Intangibles for 4 consecutive years, with $347000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Amortizatization of Intangibles rose 1926.32% year-over-year to $347000.0; the TTM figure through Mar 2026 stood at $1.9 million (up 120.12% YoY), while the FY2025 annual figure was $1.5 million, up 17.37% from the prior year.
- Amortizatization of Intangibles slipped to $347000.0 in Q1 2026 per WHWK's latest filing, from $831000.0 in the prior quarter.
- Across five years, Amortizatization of Intangibles topped out at $1.2 million in Q1 2023 and bottomed at -$19000.0 in Q1 2025.
- Historically, Amortizatization of Intangibles has averaged $485461.5 across 4 years, with a median of $422000.0 in 2024.
- Annual changes were most pronounced in 2025 — Amortizatization of Intangibles tumbled 104.5% — and 2026, when it soared 1926.32%.
- Whitehawk Therapeutics' Amortizatization of Intangibles stood at $486000.0 in 2023, then slumped by 62.35% to $183000.0 in 2024, then soared by 354.1% to $831000.0 in 2025, then tumbled by 58.24% to $347000.0 in 2026.
- Business Quant data shows WHWK's Amortizatization of Intangibles at $347000.0 in Q1 2026, $831000.0 in Q4 2025, and $717000.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 4.33 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 678,000.00 |
| 10 | Whitehawk Therapeutics | 377.13 Mn | 377.13 Mn | - | 359,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 359,000.00 |
| Mar 31, 2026 | 347,000.00 |
| Dec 31, 2025 | 831,000.00 |
| Sep 30, 2025 | 717,000.00 |
| Jun 30, 2025 | -2,000.00 |
| Mar 31, 2025 | -19,000.00 |
| Dec 31, 2024 | 183,000.00 |
| Sep 30, 2024 | 309,000.00 |
| Jun 30, 2024 | 387,000.00 |
| Mar 31, 2024 | 422,000.00 |
| Dec 31, 2023 | 486,000.00 |
| Sep 30, 2023 | 588,000.00 |
| Jun 30, 2023 | 862,000.00 |
| Mar 31, 2023 | 1.20 Mn |